AxoGen, Inc. License Agreements
9 Contracts & Agreements
- Eighth Amendment to License and Services Agreement, dated as of August 22, 2022, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissue Services) (Filed With SEC on August 25, 2022)
- Seventh Amendment to License and Services Agreement, dated as of February 22, 2021, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissues Services) (Filed With SEC on February 26, 2021)
- Fourth Amendment to License and Services Agreement, dated as of February 22, 2019, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissue Services) (Filed With SEC on February 26, 2019)
- SECOND AMENDMENT TO THE AMENDED AND RESTATED STANDARD EXCLUSIVE LICENSE AGREEMENT NO. A5140 (Filed With SEC on July 11, 2016)
- DEVELOPMENT, LICENSE & OPTION AGREEMENT (Filed With SEC on November 5, 2015)
- LICENSE AND SERVICES AGREEMENT (Filed With SEC on November 5, 2015)
- PATENT LICENSE AGREEMENT (Filed With SEC on October 6, 2011)
- AMENDED AND RESTATED STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSINGTERMS (Filed With SEC on October 6, 2011)
- Sid Martin Biotechnology Development Institute INCUBATOR LICENSE AGREEMENT (Filed With SEC on October 6, 2011)
